Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • MERS-CoV

    - PMLiVE

    MHRA marks 100 years of patient safety through biological standards

    The UK regulator highlights its century-long role in establishing safety and consistency benchmarks

    - PMLiVE

    Lilly and WHO Foundation partner to support global dementia action plan

    The partnership will provide financial support and strengthen early detection and intervention efforts

    - PMLiVE

    University of Liverpool identifies new class of antibiotic in fight against AMR

    The new antibiotic class targets two of the WHO’s ‘priority pathogens’

    - PMLiVE

    WHO urges US to ‘reconsider’ withdrawal from global health organisation

    President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

    - PMLiVE

    WHO launches $1.5bn emergency appeal to tackle ongoing health crises

    The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people

    - PMLiVE

    WHO announces priority endemic pathogens for urgent vaccine development

    The study identifies the 17 pathogens that regularly cause diseases in communities

    - PMLiVE

    WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer

    In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally

    - PMLiVE

    WHA announces progress of WHO Member States to conclude pandemic agreement

    The agreement is aimed at preventing a repeat of the global health, economic and social impacts of the COVID-19 pandemic

    - PMLiVE

    New Omicron subvariant appears more transmissible but no more severe than original Omicron strain

    The new subvariant is already emerging as a dominant strain in Denmark, the Philippines, Nepal, Qatar and India

    dengue fever mosquito

    WHO has recommended GSK’s malaria vaccine for children

    This is the first and only malaria vaccine to have been shown in pivotal long-term clinical trials to significantly reduce malaria in children

    - PMLiVE

    WHO to test three more potential COVID-19 treatments

    The expanded Solidarity PLUS trial will test artesunate, imatinib and infliximab on hospitalised COVID-19 patients in a trial that will involve thousands of researchers in 52 countries

    - PMLiVE

    EU set to contribute €1bn to COVAX

    EU had already pledged €500m to the international vaccine-sharing facility

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links